Seizures and myoclonus in patients with Alzheimer's disease

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Neurology

• Publication date

  1986-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/WNL.36.9.1226PMID 3092131
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epilepsy in Down's anomaly.

  2008cited by this paper
• The prevalance of epilepsy among mongols related to age.

  2008cited by this paper
• The EEG and incidence of epilepsy in Down's syndrome.

  2008cited by this paper
• Morphological features of Pick's and atypical Alzheimer's disease in Down's syndrome

  2004cited by this paper
• Principles of neurology

  1987cited by this paper
• Heterogeneity in dementia of the Alzheimer type

  1985cited by this paper
• [Myoclonus in Alzheimer disease].

  1985cited by this paper
• Physiologic analysis of the myoclonus of Alzheimer's disease

  1984cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Senile dementia of the Alzheimer type

  1983cited by this paper
• Alzheimer's disease: Choline acetyltransferase activity in brain tissue from clinical and pathological subgroups

  1983cited by this paper
• Dementia in Down's syndrome: observations from a neurology clinic.

  1982cited by this paper
• Alzheimer's disease and senile dementia of Alzheimer type. A comparative study.

  1982cited by this paper
• Down syndrome : advances in biomedicine and the behavioral sciences

  1982cited by this paper
• Seizures after head trauma

  1980cited by this paper
• The Epidemiology of Epilepsy in Rochester, Minnesota, 1935 Through 1967

  1975cited by this paper
• Alzheimer degeneration in Down syndrome. Electrophysiologic alterations and histopathologic findings.

  1975cited by this paper
• ALZHEIMER'S DISEASE AND RELATED CONDITIONS

  1972cited by this paper
• Observations on the brains of demented old people.

  1968cited by this paper
• Familial Alzheimer's disease

  1963cited by this paper
• GERONTO‐PSYCHIATRIC PERIOD‐PREVALENCE INVESTIGATION IN A GEOGRAPHICALLY DELIMITED POPULATION

  1962cited by this paper
• Maximum utilization of the life table method in analyzing survival.

  1958cited by this paper

• ZCCHC17: a target for synaptic dysfunction and neuronal excitability in Alzheimer's disease.

  2026cites this paper
• [Epileptic seizures in patients with Alzheimer's disease].

  2025cites this paper
• Modulation of middle-latency somatosensory evoked magnetic field waveforms associated with the pathophysiological states of Alzheimer's disease

  2025cites this paper
• The management of people with epilepsy in a city wide care home service, the impact of a GP with Special Interest in epilepsy, and Enhanced Health in Care Homes Framework.

  2025cites this paper
• Movement disorders associated with acetylcholinesterase inhibitors in Alzheimer’s dementia: A systematic review

  2025cites this paper
• Evidence that cholinergic mechanisms contribute to hyperexcitability at early stages in Alzheimer’s disease

  2025cites this paper
• Opposing interictal dynamics in Alzheimer's disease and epilepsy.

  2025cites this paper
• Functional propriospinal myoclonus in Alzheimer’s disease: coincidence or a new challenge?

  2025cites this paper
• Navigating the diagnostic challenges of myoclonus in neurodegenerative disorders: video-EEG/polygraphy, clinical vignettes, and narrative analysis

  2025cites this paper
• Microglial MS4A4A Protects against Epileptic Seizures in Alzheimer's Disease

  2025cites this paper
• Epilepsy and Alzheimer disease: New insights and perspectives.

  2025cites this paper
• Risk Factors Associated With Late-Onset Epilepsy in Dementia and Mild Cognitive Impairment.

  2025cites this paper
• Association of Seizure Control with Mortality, Cognition, and Function in People With Dementia

  2024cites this paper
• ZCCHC17 knockdown phenocopies Alzheimer's disease-related loss of synaptic proteins and hyperexcitability.

  2024cites this paper
• Diagnosing epileptic seizures in patients with Alzheimer’s disease and deciding on the appropriate treatment plan

  2024cites this paper
• Qualitative and quantitative relationships between comorbid seizures and dementia among hospitalized stroke patients.

  2024cites this paper
• Integrated multimodal cell atlas of Alzheimer’s disease

  2024cites this paper
• Prevalance of Non-Provoke Generalize Tonic-Clonic Seizure in Sporadic Alzheimer’s Disease

  2024cites this paper
• Repeated High-dose Fentanyl Administration in Rats Reveals Minimal Tolerance to Unconsciousness, Bradycardia, Muscle Rigidity, and Respiratory Depression

  2024cites this paper
• Effect of ceftriaxone on the glutamate-glutamine cycle and seizure susceptibility of Tg2576 mouse model of Alzheimer's disease

  2024cites this paper
• Interictal epileptiform discharges affect memory in an Alzheimer’s Disease mouse model

  2023cites this paper
• High Frequency Oscillations (>250Hz) Outnumber Interictal Spikes in Preclinical Studies of Alzheimer’s Disease

  2023cites this paper
• Assessment of tau phosphorylation and β‐amyloid pathology in human drug‐resistant epilepsy

  2023cites this paper
• Interictal epileptiform discharges affect memory in an Alzheimer’s disease mouse model

  2023cites this paper
• Etiology and Clinical Significance of Network Hyperexcitability in Alzheimer’s Disease: Unanswered Questions and Next Steps

  2023cites this paper
• Antiepileptic Drugs as Potential Dementia Prophylactics Following Traumatic Brain Injury.

  2023cites this paper
• Alzheimer’s disease and epilepsy: shared neuropathology guides current and future treatment strategies

  2023cites this paper
• Interictal spikes in Alzheimer’s disease: Preclinical evidence for dominance of the dentate gyrus and cholinergic control by the medial septum

  2023cites this paper
• Gamma band functional connectivity reduction in patients with amnestic mild cognitive impairment and epileptiform activity

  2022cites this paper
• Pattern and implications of neurological examination findings in autosomal dominant Alzheimer disease

  2022cites this paper
• Synaptic Disruption by Soluble Oligomers in Patients with Alzheimer’s and Parkinson’s Disease

  2022cites this paper
• The Association Between Alzheimer's Disease and Epilepsy: A Narrative Review

  2022cites this paper
• Network Preservation Analysis Reveals Dysregulated Synaptic Modules and Regulatory Hubs Shared Between Alzheimer’s Disease and Temporal Lobe Epilepsy

  2022cites this paper
• Alzheimer’s disease and epilepsy: An increasingly recognized comorbidity

  2022cites this paper
• Poststroke Seizures and the Risk of Dementia Among Young Stroke Survivors

  2022cites this paper
• Epilepsy in neurodegenerative diseases.

  2022cites this paper
• Different modes of synaptic and extrasynaptic NMDA receptor alteration in the hippocampus of P301S tau transgenic mice

  2022cites this paper
• Early death in a mouse model of Alzheimer’s disease exacerbated by microglial loss of TAM receptor signaling

  2022cites this paper
• Restoring EEG to its Rightful Place in Alzheimer Disease Care

  2021cites this paper
• Seizure susceptibility in Alzheimer’s disease

  2021cites this paper
• Systematic review of coexistent epileptic seizures and Alzheimer's disease: Incidence and prevalence

  2021cites this paper
• Amyloid-β: a potential link between epilepsy and cognitive decline

  2021cites this paper
• Synaptic dysregulation and hyperexcitability induced by intracellular amyloid beta oligomers

  2021cites this paper
• Predictors of New-Onset Epilepsy in People With Younger-Onset Neurocognitive Disorders

  2021cites this paper
• Friend or Foe? The Varied Faces of Homeostatic Synaptic Plasticity in Neurodegenerative Disease

  2021cites this paper
• Prevalence and predictors of seizure in patients with Alzheimer’s disease at a tertiary care center in Riyadh, Saudi Arabia

  2021influential citation
• Levetiracetam alleviates cognitive decline in Alzheimer’s disease animal model by ameliorating the dysfunction of the neuronal network

  2021cites this paper
• Case Report: Concomitant Alzheimer's and Lewy-Related Pathology Extending the Spectrum of Underlying Pathologies of Corticobasal Syndrome

  2021cites this paper
• References

  2021cites this paper
• Temporal Lobe Epilepsy and Alzheimer’s Disease: From Preclinical to Clinical Evidence of a Strong Association

  2021cites this paper
• Neuronal Network Excitability in Alzheimer’s Disease: The Puzzle of Similar versus Divergent Roles of Amyloid β and Tau

  2021influential citation
• Astrocyte and glutamate involvement in the pathogenesis of epilepsy in Alzheimer's disease

  2021cites this paper
• [Alzheimer disease and epilepsy].

  2021cites this paper
• APOE4 Promotes Tonic-Clonic Seizures, an Effect Modified by Familial Alzheimer’s Disease Mutations

  2021cites this paper
• Non-Convulsive Status Epilepticus in Behavioral Variant Frontotemporal Dementia

  2020cites this paper
• Dementia and epilepsy

  2020cites this paper
• Prediction of Cognitive Decline in Temporal Lobe Epilepsy and Mild Cognitive Impairment by EEG, MRI, and Neuropsychology

  2020cites this paper
• Temporal phenotyping for transitional disease progress: An application to epilepsy and Alzheimer's disease

  2020cites this paper
• Inhibitory parvalbumin basket cells are selectively impaired during hippocampal sharp wave ripples in a mouse model of familial Alzheimer ’ s disease

  2020cites this paper
• The structure and function of α, β and γ-Secretase as therapeutic target enzymes into the development of Alzheimer's disease: A review.

  2020cites this paper
• TLR4 Signaling Contributes to Post-Traumatic Epileptogenesis Through Insertion of Inwardly Rectifying AMPA Receptors: Not a Happy CP-AMPAR

  2020cites this paper
• A Study of Interactions Between Memory Disorders and Epilepsy: Epileptic Seizures in Dementia, Contrasted with Transient Epileptic Amnesia

  2020cites this paper
• Neurodegenerative pathways as targets for acquired epilepsy therapy development

  2020cites this paper
• Title Page Title: Inhibitory parvalbumin basket cell activity is selectively reduced during hippocampal sharp wave ripples in a mouse model of familial Alzheimer’s disease Abbrev Title: PVBC activity reduced during SWRs in model of AD

  2020cites this paper
• γ-Aminobutyric acid transporters as relevant biological target: Their function, structure, inhibitors and role in the therapy of different diseases.

  2020cites this paper
• Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer’s Disease

  2020cites this paper
• Epilepsy and Alzheimer's Disease: potential mechanisms for an association.

  2020cites this paper
• Neuronal chloride transporters in neurodegenerative diseases

  2020cites this paper
• Treatment of Seizures in Older Patients with Dementia

  2020cites this paper
• Electrophysiological and Imaging Calcium Biomarkers of Aging in Male and Female 5×FAD Mice

  2020cites this paper
• Unravelling the Role of Glycogen Synthase Kinase-3 in Alzheimer’s Disease-Related Epileptic Seizures

  2020cites this paper
• Understanding Alzheimer disease

  2019cites this paper
• Epilepsy and aging.

  2019cites this paper
• Unsupervised excitation: GABAergic dysfunctions in Alzheimer's disease.

  2019cites this paper
• Translational investigations of the intersection between Alzheimer’s disease and epilepsy: mechanistic insights and treatment opportunities

  2019cites this paper
• Lysyl oxidase promotes neuronal ferroptosis exacerbating seizure-induced hippocampal damage

  2019cites this paper
• Epilepsy and other neurological disorders

  2019cites this paper
• Non-motor Symptoms of Parkinson’s Disease—Considerations for Subclinical and Atypical Seizures

  2019cites this paper
• Epilepsy in the elderly: Unique challenges in an increasingly prevalent population.

  2019cites this paper
• Consequences of Metabolic Disruption in Alzheimer’s Disease Pathology

  2019cites this paper
• The overlap between epilepsy and Alzheimer’s disease and the consequences for treatment

  2019cites this paper
• Combining Representation Learning with Tensor Factorization for Risk Factor Analysis - an application to Epilepsy and Alzheimer's disease

  2019cites this paper
• Facilitation of glutamate, but not GABA, release in Familial Alzheimer's APP mutant Knock‐in rats with increased β‐cleavage of APP

  2019cites this paper
• First seizure presentations in adults: beyond assessment and treatment

  2019cites this paper
• Early Seizure Activity Accelerates Depletion of Hippocampal Neural Stem Cells and Impairs Spatial Discrimination in an Alzheimer's Disease Model.

  2019cites this paper
• New Approaches to Studying Silent Mesial Temporal Lobe Seizures in Alzheimer's Disease

  2019cites this paper
• Targeting neurodegeneration to prevent post-traumatic epilepsy.

  2019cites this paper
• Cortical developmental abnormalities in logopenic variant primary progressive aphasia with dyslexia

  2019cites this paper
• Sevoflurane increases locomotion activity in mice

  2018cites this paper
• De Novo Myoclonic Status Epilepticus After Benzodiazepine Withdrawal

  2018cites this paper
• Seizure in Alzheimer’s Disease: An Underestimated Phenomenon

  2018cites this paper
• Selecting the appropriate pharmacotherapy for epilepsy in patients with Alzheimer’s disease

  2018cites this paper
• Deficits in synaptic function occur at medial perforant path-dentate granule cell synapses prior to Schaffer collateral-CA1 pyramidal cell synapses in the novel TgF344-Alzheimer's Disease Rat Model.

  2018cites this paper
• Tau-Induced Pathology in Epilepsy and Dementia: Notions from Patients and Animal Models

  2018cites this paper
• Pharmacotherapeutic strategies for treating epilepsy in patients with Alzheimer’s disease

  2018cites this paper
• Association of Alzheimer's Disease with the Risk of Developing Epilepsy: a 10-Year Nationwide Cohort Study

  2018cites this paper
• Prevalence, Semiology, and Risk Factors of Epilepsy in Alzheimer’s Disease: An Ambulatory EEG Study

  2018cites this paper
• Myoclonic epilepsy in Down syndrome and Alzheimer disease.

  2017cites this paper
• Huperzine A: A promising anticonvulsant, disease modifying, and memory enhancing treatment option in Alzheimer's disease.

  2017cites this paper
• Levetiracetam Alters Oscillatory Connectivity in Alzheimer’s Disease

  2017cites this paper